Product Images Gabapentin
View Photos of Packaging, Labels & Appearance
- Image - 1a2df8de f3dd 43d5 983b 28151463babc 01
- Figure 1 - 1a2df8de f3dd 43d5 983b 28151463babc 02
- Figure 2 - 1a2df8de f3dd 43d5 983b 28151463babc 03
- Figure 3 - 1a2df8de f3dd 43d5 983b 28151463babc 04
- Figure 2 - 1a2df8de f3dd 43d5 983b 28151463babc 05
- 600mg-100s - 1a2df8de f3dd 43d5 983b 28151463babc 06
- 800mg-100s - 1a2df8de f3dd 43d5 983b 28151463babc 07
Product Label Images
The following 7 images provide visual information about the product associated with Gabapentin NDC 64380-727 by Strides Pharma Science Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 - 1a2df8de f3dd 43d5 983b 28151463babc 02

This text provides information about a study involving a 4-week dose titration period followed by a 4-week fixed dose period. It mentions a placebo and Gabapentin at a dosage of 3600 mg/day. Additionally, it includes a mean pain score of 10.*
Figure 3 - 1a2df8de f3dd 43d5 983b 28151463babc 04

This text provides information regarding the preparation of responders (patients with a 50% reduction in pain score) at the endpoint in Controlled PHN Studies. It includes data from two studies showing the percentage of responders in Study 1 as 34% and Study 2 as 29%. Additionally, it includes the names of different medications or treatments such as GEP 3600, GBP 1800, and GBF 2400.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.